Virpax Pharmaceuticals Reports 2021 Second Quarter Results and Recent Developments
BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (Virpax or the Company) (NASDAQ:VRPX), today announced its financial results for the quarter ended June 30, 2021, and other recent developments.
We continue to advance our product candidate pipeline…
